Halipa, Jaharia .
HRN: 18-69-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2025
COTRIMOXAZOLE 960MG (TAB)
12/14/2025
12/20/2025
PO
960mg
Q12
T/C Catheter Associated UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes